These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22340708)

  • 1. Mitochondrial fission proteins in peripheral blood lymphocytes are potential biomarkers for Alzheimer's disease.
    Wang S; Song J; Tan M; Albers KM; Jia J
    Eur J Neurol; 2012 Jul; 19(7):1015-22. PubMed ID: 22340708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
    Tan M; Wang S; Song J; Jia J
    Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
    Bossy B; Petrilli A; Klinglmayr E; Chen J; Lütz-Meindl U; Knott AB; Masliah E; Schwarzenbacher R; Bossy-Wetzel E
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G1/S checkpoint proteins in peripheral blood lymphocytes are potentially diagnostic biomarkers for Alzheimer's disease.
    Song J; Wang S; Tan M; Jia J
    Neurosci Lett; 2012 Sep; 526(2):144-9. PubMed ID: 22922216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Mitochondrial Dynamic-related Genes in the Peripheral Blood of Alzheimer's Disease Patients.
    Pakpian N; Phopin K; Kitidee K; Govitrapong P; Wongchitrat P
    Curr Alzheimer Res; 2020; 17(7):616-625. PubMed ID: 33023448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of Mitochondrial Fission Proteins in Membranous Nephropathy in Children.
    Wei QJ; Xu H; Guan N; Ren YL; Liu XY; Wu GH; Zhu SN
    Kidney Blood Press Res; 2018; 43(6):1927-1934. PubMed ID: 30566949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease.
    Liang F; Jia J; Wang S; Qin W; Liu G
    J Clin Neurosci; 2013 Mar; 20(3):357-61. PubMed ID: 23228658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease.
    Joshi AU; Saw NL; Shamloo M; Mochly-Rosen D
    Oncotarget; 2018 Jan; 9(5):6128-6143. PubMed ID: 29464060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
    Caza TN; Fernandez DR; Talaber G; Oaks Z; Haas M; Madaio MP; Lai ZW; Miklossy G; Singh RR; Chudakov DM; Malorni W; Middleton F; Banki K; Perl A
    Ann Rheum Dis; 2014 Oct; 73(10):1888-97. PubMed ID: 23897774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1.
    Mai S; Klinkenberg M; Auburger G; Bereiter-Hahn J; Jendrach M
    J Cell Sci; 2010 Mar; 123(Pt 6):917-26. PubMed ID: 20179104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia.
    Olsson B; Hertze J; Ohlsson M; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Zetterberg H; Blennow K; Hansson O
    J Alzheimers Dis; 2013; 34(3):673-9. PubMed ID: 23254629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
    Jongbloed W; Kester MI; van der Flier WM; Veerhuis R; Scheltens P; Blankenstein MA; Teunissen CE
    Alzheimers Dement; 2013 May; 9(3):276-83. PubMed ID: 23110867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases.
    Wang S; Zhang C; Sheng X; Zhang X; Wang B; Zhang G
    J Clin Neurosci; 2014 May; 21(5):810-4. PubMed ID: 24405770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease.
    Peng M; Jia J; Qin W
    Neurosci Lett; 2015 May; 595():116-21. PubMed ID: 25864780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
    Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the value of plasma BIN1 as a potential biomarker for alzheimer's disease.
    Sun L; Tan MS; Hu N; Yu JT; Tan L
    J Alzheimers Dis; 2013; 37(2):291-5. PubMed ID: 23803295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential utility of soluble p3-alcadein α plasma levels as a biomarker for sporadic Alzheimer's disease.
    Kamogawa K; Kohara K; Tabara Y; Takita R; Miki T; Konno T; Hata S; Suzuki T
    J Alzheimers Dis; 2012; 31(2):421-8. PubMed ID: 22571980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease.
    Chiasserini D; Parnetti L; Andreasson U; Zetterberg H; Giannandrea D; Calabresi P; Blennow K
    J Alzheimers Dis; 2010; 22(4):1281-8. PubMed ID: 20930282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
    Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.